TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
OGN

Organon & Co

Healthcare · Drug Manufacturers - General

13.70$ +0.0% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Cash Flow

Organon & Co (OGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at 107 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow OGN
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
261 397 76 332 141 390 75 220 264 141 225 107 737
61 60 65 66 69 77 84 89 92 240 86 -86 332
27 27 26 28 25 26 24 22 24 7.0 19 -19 31
52 – – – – – – – – – – – –
90 225 -223 -301 -167 112 -125 -61 -27 -34 42 -42 -61
55 81 96 32 76 132 97 39 115 45 37 42 239
-179 -81 -96 -46 -75 -296 -172 -38 -115 -65 386 -76 130
74 73 70 79 74 74 71 10 3.0 4.0 5.0 6.0 18
-2.0 -2.0 -2.0 -14 -2.0 -4.0 -1.0 -12 -1.0 – – – –
-2.0 – – – -2.0 -2.0 -3.0 -201 -72 -182 -32 0.0 -286
-78 -77 -74 -134 -78 -82 -75 -223 -76 -187 -38 -12 -313
88 279 -118 129 59 -88 -128 52 73 -98 542 16 533
206 316 -20 300 65 258 -22 181 149 96 188 65 498

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?